Cargando…
The use and misuse of risk prediction tools for clinical decision-making
Autores principales: | van Maaren, Marissa C., Hueting, Tom A., Völkel, Vinzenz, van Hezewijk, Marjan, Strobbe, Luc JA., Siesling, Sabine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300578/ https://www.ncbi.nlm.nih.gov/pubmed/36709092 http://dx.doi.org/10.1016/j.breast.2023.01.006 |
Ejemplares similares
-
Improved risk estimation of locoregional recurrence, secondary contralateral tumors and distant metastases in early breast cancer: the INFLUENCE 2.0 model
por: Völkel, Vinzenz, et al.
Publicado: (2021) -
External validation of 87 clinical prediction models supporting clinical decisions for breast cancer patients
por: Hueting, Tom A., et al.
Publicado: (2023) -
Breast-conserving therapy versus mastectomy
por: van Maaren, Marissa C., et al.
Publicado: (2016) -
Explainable machine learning can outperform Cox regression predictions and provide insights in breast cancer survival
por: Moncada-Torres, Arturo, et al.
Publicado: (2021) -
Needs and preferences of breast cancer survivors regarding outcome-based shared decision-making about personalised post-treatment surveillance
por: Ankersmid, Jet W., et al.
Publicado: (2022)